Novanta Inc. (NASDAQ:NOVT) CFO Robert Buckley sold 3,704 shares of the business’s stock in a transaction dated Monday, April 5th. The shares were sold at an average price of $136.02, for a total value of $503,818.08. Following the completion of the transaction, the chief financial officer now owns 158,198 shares in the company, valued at approximately $21,518,091.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Novanta stock opened at $134.18 on Thursday. Novanta Inc. has a one year low of $75.87 and a one year high of $146.16. The company’s fifty day moving average price is $132.46 and its two-hundred day moving average price is $123.28. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.27 and a quick ratio of 1.51. The company has a market capitalization of $4.75 billion, a price-to-earnings ratio of 115.67 and a beta of 1.09.
Novanta (NASDAQ:NOVT) last posted its earnings results on Sunday, February 28th. The technology company reported $0.53 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.44 by $0.09. Novanta had a return on equity of 16.33% and a net margin of 6.81%. The firm had revenue of $147.50 million during the quarter, compared to analyst estimates of $147.05 million. During the same period in the previous year, the company earned $0.55 EPS. The company’s revenue for the quarter was down 7.6% on a year-over-year basis. As a group, sell-side analysts anticipate that Novanta Inc. will post 1.85 earnings per share for the current year.
A number of research firms have recently weighed in on NOVT. TheStreet upgraded Novanta from a “c+” rating to a “b” rating in a report on Monday, March 1st. Zacks Investment Research lowered shares of Novanta from a “hold” rating to a “sell” rating in a research report on Thursday, March 4th.
Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. Its Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products for photonics-based applications, such as industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
Featured Story: Understanding each part of a balance sheet
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.